Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Chlormadinone |
EINECS | 217-802-3 |
CAS No. | 1961-77-9 | Density | 1.24 g/cm3 |
PSA | 54.37000 | LogP | 4.18090 |
Solubility | N/A | Melting Point |
213°C |
Formula | C21H27 Cl O3 | Boiling Point | 506.7 °C at 760 mmHg |
Molecular Weight | 362.897 | Flash Point | 260.2 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Human reproductive effects by ingestion: changes in the uterus, cervix, vagina, and female fertility. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of Cl−. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
6-Chloro-6-dehydro-17-hydroxyprogesterone;6-Chloro-6-dehydro-17a-hydroxyprogesterone;Chlormadinon;Chlormadinone; |
Article Data | 9 |
drug name : chlorine to progesterone
English : Chlormadinone
AcetateFormula :C21H27ClO3
Mol. mass :362.89 g/mol
Indications : k potent oral progesterone, not estrogen and androgen activity. Anti ovulation Norethisterone role of 18.4 times, and long-term estrogen propargyl ether estrogen component compatibility estrogen compound propargyl ether films, as long-acting oral contraceptives, a meeting of medication, on the 25th of contraception, such as increased Norethisterone A formation of a new "triple propargyl ether estrogen tablets," better clinical results.
Note :
1. Beginning nausea, vomiting, dizziness, weakness, loss of appetite, increased leucorrhea, breasts bulging other adverse reactions, but with the time taken to extend or reduce the symptoms disappear. Individual or by the increase in the volume of short-term amenorrhea.
2. Long-term medication, a few have hypertension and mild changes in glucose metabolism, hypertension and therefore had a history of diabetes patients with caution.
3. Liver disease, nephritis, uterine fibroids, breast lumps, breast-feeding women hanged.
4. If the medication two cycles, menstrual not ebb, withdrawal, and to exclude the possibility of pregnancy.